Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

MNG938

e80a8257-3c86-54b5-8c9b-ac4ce3430eec

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • INTERFERON_ALPHA_RESPONSE+0.397
  • UV_RESPONSE_DN+0.218
  • WNT_BETA_CATENIN_SIGNALING+0.197
  • MITOTIC_SPINDLE+0.181
  • DNA_REPAIR+0.168
  • MYC_TARGETS_V2+0.077
  • APICAL_JUNCTION+0.033
  • PEROXISOME+0.022
  • UNFOLDED_PROTEIN_RESPONSE+0.021
  • INTERFERON_GAMMA_RESPONSE+0.002

Top 10 suppressed

  • TNFA_SIGNALING_VIA_NFKB-0.493
  • MTORC1_SIGNALING-0.452
  • ANGIOGENESIS-0.442
  • PANCREAS_BETA_CELLS-0.419
  • INFLAMMATORY_RESPONSE-0.414
  • CHOLESTEROL_HOMEOSTASIS-0.403
  • ALLOGRAFT_REJECTION-0.385
  • APICAL_SURFACE-0.376
  • COMPLEMENT-0.337
  • ESTROGEN_RESPONSE_LATE-0.336

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1MNG230
mng-umap@100
0.842
2MNG909
mng-umap@100
0.818
3MDT-AP-0329
medullo-epn-umap@date-based
MedMedulloblastoma0.807
4MNG881
mng-umap@100
0.803
5MBCproject_6016_T1_RNA
breast-umap@18
A0.793
6SRR4296062
lung-landscapes@6
cohortA10.792
7MNG54
mng-umap@100
0.792
8aMVAC.P_002_TURBT_S219
bladder-landscape@3
0.776
9SRR5088920
melanoma-umap@29
0.768
10SRR650134
bladder-landscape@3
0.767

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 10 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
INTERFERON_ALPHA_RESPONSE0.397Inavolisib— uncovered
UV_RESPONSE_DN0.218Inavolisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.197Inavolisib— uncovered
MITOTIC_SPINDLE0.181Inavolisib— uncovered
DNA_REPAIR0.168Idelalisib— uncovered
MYC_TARGETS_V20.077Idelalisib— uncovered
APICAL_JUNCTION0.033Inavolisib— uncovered
PEROXISOME0.022Idelalisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.021Idelalisib— uncovered
INTERFERON_GAMMA_RESPONSE0.002Idelalisib— uncovered